We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Drug Isolated from Chinese Medicinal Plant Blocks RNA Synthesis

By LabMedica International staff writers
Posted on 22 Mar 2011
Print article
The mode of action of triptolide, the active ingredient of the Chinese medicinal plant thunder-god vine, or lei gong teng, and a potential new anticancer drug has been elucidated in a recently published paper.

Triptolide, the active ingredient purified from the plant Tripterygium wilfordii Hook F, has been shown in animal models to be effective against cancer, arthritis, and skin graft rejection. In the current study investigators at Johns Hopkins University (Baltimore, MD, USA) worked with cultures of HeLa cells, on which they tested triptolide's effect on different proteins involved with gene control by looking at how much new DNA, RNA, and protein were made by the cells.

They reported in the March 2011 issue of the journal Nature Chemical Biology that triptolide almost immediately blocked manufacture of new RNA while taking much longer to have an effect on the levels of newly made proteins or DNA.

They found that triptolide bound covalently to the protein XPB (also known as ERCC3 or excision repair cross-complementing rodent repair deficiency, complementation group 3 xeroderma pigmentosum group B complementing), a subunit of the transcription factor TFIIH. This binding inhibited XPB's DNA-dependent ATPase activity, which led to the inhibition of RNA polymerase II (RNAPII)–mediated transcription and likely nucleotide excision repair. The identification of XPB as the target of triptolide accounted for the majority of the drug's known biological activity.

"Extracts of this medicinal plant have been used to treat a whole host of conditions and have been highly lauded for anti-inflammatory, immunosuppressive, contraceptive, and antitumor activities," said senior author Dr. Jun O. Liu, professor of pharmacology and molecular sciences at Johns Hopkins University. "We have known about the active compound, triptolide, and that it stops cell growth, since 1972, but only now have we figured out what it does.”

"Triptolide's general ability to stop RNAPII activity explains its anti-inflammatory and anticancer effects," said Dr. Liu. "And its behavior has important additional implications for circumventing the resistance that some cancer cells develop to certain anticancer drugs. We are eager to study it further to see what it can do for future cancer therapy.”

Related Links:
Johns Hopkins University

Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.